SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Leung Y.)
 

Search: WFRF:(Leung Y.) > (2005-2009) > Independent and com...

Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.

Johannsson, Gudmundur, 1960 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin,Institute of Internal Medicine
Gibney, James (author)
Wolthers, Troels (author)
show more...
Leung, Kin-Chuen (author)
Ho, Ken K Y (author)
show less...
 (creator_code:org_t)
The Endocrine Society, 2005
2005
English.
In: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 90:7, s. 3989-94
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • CONTEXT: Symptoms of fluid retention in GH-deficient patients during GH replacement are greater in men than in women, suggesting that testosterone may augment or estradiol may attenuate the antinatriuretic actions of GH. The mechanisms underlying the sodium-retaining effects of GH are poorly understood. AIM: The aim of this study was to investigate the effects of GH and testosterone, alone and in combination, on extracellular water (ECW) and the hormonal mechanisms involved. DESIGN: Two separate, open-label, randomized, two-period, crossover studies were performed; the first compared the effects of GH alone with those of GH and testosterone, and the second compared the effects of testosterone alone with those of GH and testosterone. PARTICIPANTS: Twelve hypopituitary men with GH deficiency and hypogonadism were studied. INTERVENTION: During the weeks of intervention, GH (0.5 mg/d) and testosterone enanthate (250 mg) were administered by im injection. OUTCOME MEASURES: The outcome measures were ECW, IGF-I, plasma renin activity (PRA), aldosterone (Aldo), and atrial natriuretic peptide (ANP). RESULTS: GH treatment significantly increased (P < 0.05) both IGF-I and ECW, and these changes were enhanced by cotreatment with testosterone (P = 0.07 for both). PRA, Aldo, and ANP levels did not change. Testosterone treatment alone did not change the IGF-I concentration, whereas cotreatment with GH induced a marked increase. Testosterone alone increased (P < 0.05) ECW, and the effect was augmented (P < 0.01) by cotreatment with GH. Although PRA and ANP did not change, plasma Aldo decreased after single and combined treatments. CONCLUSION: GH and testosterone exerted independent and additive effects on ECW. The mechanisms of fluid retention for both hormones are likely to be exerted on the renal tubules. This is the first direct evidence that testosterone increases ECW.

Keyword

Adult
Aged
Aldosterone
blood
Atrial Natriuretic Factor
blood
Body Water
metabolism
Cross-Over Studies
Drug Synergism
Extracellular Fluid
metabolism
Hormone Replacement Therapy
Human Growth Hormone
deficiency
therapeutic use
Humans
Hypopituitarism
drug therapy
metabolism
Insulin-Like Growth Factor I
analysis
Male
Middle Aged
Testosterone
therapeutic use

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view